Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,951 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2.
Fang Z, Peng L, Filler R, Suzuki K, McNamara A, Lin Q, Renauer PA, Yang L, Menasche B, Sanchez A, Ren P, Xiong Q, Strine M, Clark P, Lin C, Ko AI, Grubaugh ND, Wilen CB, Chen S. Fang Z, et al. Among authors: ren p. bioRxiv [Preprint]. 2022 Feb 28:2022.02.14.480449. doi: 10.1101/2022.02.14.480449. bioRxiv. 2022. Update in: Nat Commun. 2022 Jun 6;13(1):3250. doi: 10.1038/s41467-022-30878-4 PMID: 35194606 Free PMC article. Updated. Preprint.
Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617.
Peng L, Hu Y, Mankowski MC, Ren P, Chen RE, Wei J, Zhao M, Li T, Tripler T, Ye L, Chow RD, Fang Z, Wu C, Dong MB, Cook M, Wang G, Clark P, Nelson B, Klein D, Sutton R, Diamond MS, Wilen CB, Xiong Y, Chen S. Peng L, et al. Among authors: ren p. bioRxiv [Preprint]. 2021 Dec 24:2021.12.21.473733. doi: 10.1101/2021.12.21.473733. bioRxiv. 2021. Update in: Nat Commun. 2022 Mar 28;13(1):1638. doi: 10.1038/s41467-022-29288-3 PMID: 34981065 Free PMC article. Updated. Preprint.
Function and Cryo-EM structures of broadly potent bispecific antibodies against multiple SARS-CoV-2 Omicron sublineages.
Ren P, Hu Y, Peng L, Yang L, Suzuki K, Fang Z, Bai M, Zhou L, Feng Y, Zou Y, Xiong Y, Chen S. Ren P, et al. bioRxiv [Preprint]. 2023 Mar 15:2022.08.09.503414. doi: 10.1101/2022.08.09.503414. bioRxiv. 2023. Update in: Signal Transduct Target Ther. 2023 Jul 31;8(1):281. doi: 10.1038/s41392-023-01509-1 PMID: 35982661 Free PMC article. Updated. Preprint.
A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.
Liu Y, Zhang X, Liu J, Xia H, Zou J, Muruato AE, Periasamy S, Plante JA, Bopp NE, Kurhade C, Bukreyev A, Ren P, Wang T, Menachery VD, Plante KS, Xie X, Weaver SC, Shi PY. Liu Y, et al. Among authors: ren p. bioRxiv [Preprint]. 2022 Feb 15:2022.02.14.480460. doi: 10.1101/2022.02.14.480460. bioRxiv. 2022. Update in: Nat Commun. 2022 Jul 27;13(1):4337. doi: 10.1038/s41467-022-31930-z PMID: 35194609 Free PMC article. Updated. Preprint.
Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants.
Jaworski E, Langsjoen RM, Mitchell B, Judy B, Newman P, Plante JA, Plante KS, Miller AL, Zhou Y, Swetnam D, Sotcheff S, Morris V, Saada N, Machado R, McConnell A, Widen S, Thompson J, Dong J, Ren P, Pyles RB, Ksiazek T, Menachery VD, Weaver SC, Routh A. Jaworski E, et al. Among authors: ren p. bioRxiv [Preprint]. 2021 Sep 1:2021.03.10.434828. doi: 10.1101/2021.03.10.434828. bioRxiv. 2021. Update in: Elife. 2021 Sep 28;10:e68479. doi: 10.7554/eLife.68479 PMID: 33758846 Free PMC article. Updated. Preprint.
1,951 results